Next generation CD44v6-specific CAR-NK cells for the treatment of solid tumors

被引：0
|
作者：
Pecher, Gabriele
Franzen, Alexander Sebastian
Boulifa, Abdelhadi
Radecke, Clarissa
Stintzing, Sebastian
Raftery, Martin
机构：
[1] Charite, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] INCORPORATION OF 2B4 SIGNALING DOMAIN IN ANTI-CD19 NK-SPECIFIC CARS INCREASES THE POTENCY OF EFFECTOR FUNCTIONS OF CAR-NK CELLS AGAINST MALIGNANT CD19+CELL LINES
    dos Santos, M. H.
    de Azevedo, J. T.
    Silvestre, R. N.
    Rodrigues, R. D. de Saloma
    Covas, D. T.
    Picanco-Castro, V.
    CYTOTHERAPY, 2023, 25 (06) : S220 - S220
  • [42] In vivo antitumor activity of a hCD44v6-specific chimeric antigen receptor in syngeneic models of solid tumors
    Martinez-de-la-Torre, Y.
    Tiziano, E.
    Valtolina, V.
    Porcellini, S.
    Stornaiuolo, A.
    Bordignon, C.
    Traversari, C.
    HUMAN GENE THERAPY, 2018, 29 (12) : A22 - A22
  • [43] DUAL TARGETING OF PD-L1 AND ERBB2 BY CAR-NK CELLS ENABLES SPECIFIC ELIMINATION OF SOLID TUMOR CELLS AND OVERCOMES IMMUNE ESCAPE VIA ANTIGEN LOSS
    Eitler, J.
    Freudenberg, K.
    Ben-Horin, I.
    Montero, P.
    Rackwitz, W.
    Wels, W.
    Tonn, T.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A15 - A16
  • [44] Dual Transgenesis of T Cells with a CD44v6 CAR and a Suicide Gene for the Safe Eradication of Myeloid Leukemia and Myeloma
    Casucci, Monica
    Falcone, Laura
    di Robilant, Benedetta Nicolis
    Camisa, Barbara
    Genovese, Pietro
    Gentner, Bernhard
    Naldini, Luigi
    Savoldo, Barbara
    Ciceri, Fabio
    Bordignon, Claudio
    Dotti, Gianpietro
    Bonini, Chiara
    Bondanza, Attilio
    MOLECULAR THERAPY, 2012, 20 : S180 - S181
  • [45] CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice
    Porcellini, Simona
    Asperti, Claudia
    Corna, Stefano
    Cicoria, Eleonora
    Valtolina, Veronica
    Stornaiuolo, Anna
    Valentinis, Barbara
    Bordignon, Claudio
    Traversari, Catia
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] Demethylating therapy increases cytotoxicity of CD44v6 CAR-T cells against acute myeloid leukemia
    Tang, Ling
    Kong, Yingjie
    Wang, Haobing
    Zou, Ping
    Sun, Ting
    Liu, Ying
    Zhang, Juan
    Jin, Na
    Mao, Hanwen
    Zhu, Xiaojian
    Wang, Jue
    Meng, Fankai
    You, Yong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation
    Luo, Jianhua
    Guo, Meng
    Huang, Mingyan
    Liu, Yanfang
    Qian, Yuping
    Liu, Qiuyan
    Cao, Xuetao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [48] A new fully humanized transgenic mouse model for predicting the hematological toxicities of CD44v6-CAR T cells
    Norelli, M.
    Casucci, M.
    Camisa, B.
    Falcone, L.
    Oliveira, G.
    Genovese, P.
    Saudemont, A.
    Bordignon, C.
    Naldini, L.
    Dotti, G.
    Bonini, C.
    Bondanza, A.
    HUMAN GENE THERAPY, 2013, 24 (12) : A45 - A45
  • [49] DUAL TARGETING OF CAR-NK CELLS TO PD-L1 AND HER2 FACILITATES SPECIFIC ELIMINATION OF CANCER CELLS OF SOLID TUMOR ORIGIN AND OVERCOMES IMMUNE ESCAPE BY ANTIGEN LOSS
    Eitler, J.
    Freudenberg, K.
    Montero, P. O.
    Rackwitz, W.
    Wels, W. S.
    Tonn, T.
    CYTOTHERAPY, 2023, 25 (06) : S221 - S222
  • [50] DUAL TARGETING OF CAR-NK CELLS TO PD-L1 AND HER2 FACILITATES SPECIFIC ELIMINATION OF CANCER CELLS OF SOLID TUMOR ORIGIN AND OVERCOMES IMMUNE ESCAPE BY ANTIGEN LOSS
    Eitler, J.
    Freudenberg, K.
    Montero, P.
    Wels, W.
    Tonn, T.
    CYTOTHERAPY, 2022, 24 (05) : S127 - S128
12345